Dr Martin Juneau, M.D., FRCPCardiologue et Directeur de la prévention, Institut de Cardiologie de Montréal. Professeur titulaire de clinique, Faculté de médecine de l'Université de Montréal. / Cardiologist and Director of Prevention, Montreal Heart Institute. Clinical Professor, Faculty of Medicine, University of Montreal.30 January 2023
This is an updated version of an article originally published in 2018
Even though alcohol has been a daily part of human existence for millennia, the substance is far from innocuous and in fact has very complex effects on health. This complexity is well illustrated by the J-shaped relationship between the quantity of alcohol consumed and the risk of premature death observed in a large number of epidemiological studies. One large-scale study, carried out among more than 300,000 people followed for nearly 10 years, shows that moderate alcohol consumption (3 to 14 glasses per week for men and 3 to 7 glasses for women) is associated with an approximately 20% lower risk of all-cause mortality compared to non-drinkers (Figure 1). This protective window is very narrow, however, with a rapid increase in mortality risk observed at higher quantities.
Figure 1. Relationship between alcohol consumption and the risk of premature death. The maximum risk reduction observed in the study (– 0.1 log) corresponds to a reduction of approximately 20% in risk. Adapted from Xi et al. (2017).
As a reminder, what is commonly considered a “glass” or a “standard drink” refers to the quantity of alcoholic drink that leads to the absorption of approximately 12 to 15 grams of pure alcohol (Table 1). The size of a glass therefore directly depends on the alcohol content of the drink consumed.
Table 1. Alcohol content of the main types of alcoholic beverages. Adapted from Educ’alcool.
|Type of alcoholic beverage||One standard drink equals:
|Beer (5% alc/vol)||340 mL (12 oz.)
|Wine (12% alc/vol)||140 mL (5 oz.)
|Fortified wine (e.g. Port) (20% alc/vol)||85 mL (3 oz.)
|Spirits (40% alc/vol) ||45 mL (1.5 oz.)
However, the protective effect of low doses of alcohol on mortality has been called into question by a major study recently published in The Lancet. In this study, which analyzed the alcohol consumption habits of about 600,000 drinkers, the authors did not observe a decrease in mortality, even at low amounts of alcohol, but rather a significant increase in the risk of premature death starting at 100 g of alcohol per week, which only equals one drink per day (Figure 2A). In contrast, analysis of the same data revealed a lower risk of cardiovascular mortality, consistent with hundreds of studies that have observed a cardioprotective effect resulting from moderate alcohol consumption (Figure 2B). Nevertheless, the authors suggest that the amounts of alcohol that are currently recommended (1 drink daily for women, two for men) are too high and that these limits should be lowered. Another study, also published in The Lancet, draws similar conclusions, specifically that intake as low as only one glass per day is associated with an increased risk of developing one of the 23 pathologies associated with alcohol consumption, and, according to the authors, that there does not appear to be a safe level of alcohol consumption. Yet, as some experts have pointed out, this approach is a bit “absolutist”, since the increased risk observed at low amounts of alcohol was extremely low, going from 0.914 percent in non-drinkers to 0.918 in those who consumed one glass a day and to 0.977 for those who drank two glasses a day. Therefore, for moderate drinkers, the actual risk associated with alcohol consumption is for all intents and purposes negligible.
Figure 2. Relationship between alcohol consumption (in g per week) and the risk of premature all-cause mortality (A) or cardiovascular mortality (B) calculated from a synthesis of 83 epidemiological studies involving 600,000 participants. Adapted from Wood et al. (2018).
At this stage, it is difficult to say whether these recent studies are superior to previous ones and if moderate alcohol consumption is indeed devoid of any beneficial effects on mortality (see box). Each epidemiological study has its strengths and weaknesses, and the only true method to resolve this ambiguity would be to conduct a randomized clinical study where the health of moderate drinkers could be compared to that of non-drinkers, but such a study is not feasible due to ethical considerations. In any event, a cautious interpretation of all these studies is to state that the negative effects of alcohol should certainly not be trivialized, and that it is important to drink very moderately to take advantage of its potential benefits while avoiding its well-documented harmful effects (Table 2). Historically, the maximum amounts of alcohol considered to be associated with health benefits are 1-3 glasses per day for men and 1-2 glasses per day for women. At these low levels, alcohol increases HDL cholesterol levels, improves glycemic control, and has anticoagulant and anti-inflammatory properties, all of which contributes to reducing the risk of cardiovascular events, notably myocardial infarction. In light of the results of the two studies published in The Lancet, it would seem advisable to slightly lower these limits to 2 glasses a day for men and 1 glass a day for women.
Cardioprotection by alcohol is not a myth
In recent years, a fairly radical current of thought has emerged claiming that the cardiovascular benefits of alcohol are a “myth” and that there is no safe level of consumption. This message, conveyed by organizations such as the WHO and the Canadian Centre on Substance Use and Addiction (CCSA), is, however, based on a rather limited reading of research; for example, in the recent CCSA report, the analysts selected only 16 studies out of more than 5,000 publications available, which necessarily increases the risk of bias. But even under these conditions, the report clearly shows a reduced risk of ischemic heart disease at low levels of alcohol consumption, in agreement with hundreds of major studies that have focused on this issue, including the study published in The Lancet mentioned earlier (Figure 2B). The CCSA’s conclusion that there is no health benefit associated with moderate alcohol consumption therefore contradicts their own findings and the body of evidence accumulated over the past 30 years, particularly with regard to reducing the risk of ischemic heart disease such as myocardial infarction, the leading cause of cardiovascular mortality. A similar dissonance is found in a recent article, in which the authors claim that alcohol cardioprotection is a “myth”, while at the same time presenting data showing a strong decrease in the risk of ischemic heart disease. In other words, the research findings on the positive impact of low-dose alcohol on cardiovascular mortality do not justify the conclusion that there is no safe threshold for alcohol consumption. In our opinion, the recommendations of very serious organizations such as the Harvard School of Public Health and the National Institute on Alcohol Abuse and Alcoholism NIAAA), i.e., a daily consumption of 2 glasses for men and 1 drink for women, remain the most relevant.
Above these levels, however, consumption is clearly abusive, since it is associated with an increased risk of several cancers, in particular oral, laryngeal, esophageal, colon, liver and breast cancer. Chronic consumption of large quantities of alcohol is also associated with several cardiovascular diseases, including atherosclerosis, hypertension, some cardiomyopathies as well as arrhythmias, which considerably increase the risk of cardiovascular mortality. It should also be noted that binge drinking, where large amounts of alcohol can be consumed in a short amount of time, is also associated with several harmful effects, in particular a much higher risk of stroke.
Table 2. The different types of alcohol consumption. Adapted from Fernández-Solà (2015).
|Type of consumption||Pure alcohol (g)||Standard drinks||Effect on health
|< 20 g per day (men) |
< 10 g per day (women)
|Moderate||20-45 g per day (men)|
10-30 g per day (women)
|Controversial, could depend on the type of alcohol
|> 45 g per day (men)|
> 30 g per day (women)
|More than 3 glasses|
More than 2 glasses
|> 60 g in one sitting||4 glasses or more||Negative
Alcohol is thus a formidable double-edged sword, and it is important to limit daily alcohol consumption to low levels, ideally a maximum of 2 glasses per day for men and 1 glass for women, and most likely a bit less.
Opt for red wine
Red wine is a complex beverage containing several milligrams of phenolic compounds (specifically resveratrol), which are extracted from grape skin during the fermentation process. These molecules have antioxidant, anti-inflammatory, antiplatelet, and vasodilator properties, which suggests that red wine could have more significant positive effects than those associated simply with the presence of alcohol.
One of the foremost examples of these benefits is the famous “French paradox”, where regularly drinking red wine would be responsible for the low incidence of coronary heart disease observed in France compared to other Western countries, despite a diet high in saturated fats. This beneficial effect is supported by a Danish study, which showed that the risk of premature death was three times lower in moderate red wine drinkers than in those who drink beer or spirits, and also by the results of other studies conducted in Northern California and in Eastern France.
Another argument in favour of choosing red wine is its lower impact on the risk of cancer, possibly due to its resveratrol content. In laboratories, this molecule has one of the most powerful anticancer effects in the plant world and could thus counteract the carcinogenic effect of alcohol. For example, a study showed that whereas the moderate consumption of alcoholic beverages other than wine increases the risk of oral cancer by 38%, this increased risk lowers to only 7% in red wine drinkers. A similar phenomenon is observed for lung cancer, where moderate wine consumption is associated with a reduced risk of this cancer, whereas consumption of beer and spirits increases the risk. It would therefore appear that the greatest decrease in mortality associated with red wine consumption observed in several studies is not only associated with a more pronounced protective effect on the risk of heart disease but also with a less harmful effect on the risk of cancer than other types of alcohol. This phenomenon was also observed in the study published in The Lancet mentioned above. When the authors examined mortality according to the type of alcohol consumed, they observed an enormous difference in risk between wine and other types of alcohol, with red wine consumption (up to 300 g per week) being associated with a slight 10% increase in mortality, which is much lower than that observed in beer and spirit drinkers (Figure 3).
Figure 3. Relationship between the type of alcohol consumed (in grams per week) and the risk of premature death. Adapted from Wood et al. (2018).
The superiority of red wine over other types of alcohol is also suggested by a recent study on the association between alcohol consumption and the risk of atrial fibrillation (AF), an arrhythmia that significantly increases the risk of stroke. In this study, the researchers observed that moderate alcohol consumption in general (7 glasses per week or less) was associated with a small decrease in the risk of AF, but that this risk increased significantly at higher amounts (14 glasses and more per week). However, when the same analysis was carried out taking into account the type of alcohol consumed, it was observed that the risk of AF did not increase in people who drank up to 14 glasses of red wine per week (Figure 4). White wine also seems to minimize the risk of AF, but to a lesser degree (increased risk starting at 10 glasses per week), while beer and spirits increase this risk very quickly, starting from about 3 glasses per week.
Figure 4. Relationship between the type of alcohol consumed (in standard drinks per week) and the risk of atrial fibrillation. Note that one drink is the British standard unit of 8 g (10 mL) of alcohol. The gray areas represent the 95% confidence intervals. Adapted from Tu et al. (2021).
Overall, these observations confirm the results of the INTERHEART study and those of the Åkesson group, which show that moderate consumption of alcohol represents one of the lifestyle factors that can contribute to a lower risk of coronary heart disease and early death. A recent study demonstrates to what extent the impact of lifestyle habits can be extraordinary: 50-year-olds who don’t smoke, have a healthy diet, do 30 minutes or more of daily physical activity, maintain a healthy weight (BMI between 19 and 25), and drink moderately (5-15 g/day for women, 5-30 g/day for men) have 82% less risk of dying from heart disease and 65% less risk of dying of cancer. In practice, this translates to a 14-year increase in life expectancy for women and 12 years for men! Thus, to truly be beneficial, alcohol consumption should be part of an overall healthy lifestyle, including a diet high in plant-based foods, regular physical activity, maintaining a normal body weight, and, of course, not smoking.
Dr Martin Juneau, M.D., FRCPCardiologue et Directeur de la prévention, Institut de Cardiologie de Montréal. Professeur titulaire de clinique, Faculté de médecine de l'Université de Montréal. / Cardiologist and Director of Prevention, Montreal Heart Institute. Clinical Professor, Faculty of Medicine, University of Montreal.25 January 2023
- The composition of the intestinal microbiota has a significant effect on the motivation of laboratory mice to exercise, according to a recently published study.
- Two intestinal bacteria are particularly associated with better performance during exercise: Eubacterium rectaleand Coprococcus eutactus.
- These bacteria produce metabolites, fatty acid amides (FAA), which bind to the type-1 cannabinoid receptor (CB1), located in the sensory nerves in the intestine, and are connected to the brain via the spinal cord.
- Stimulation of the CB1 receptor causes an increase in dopamine levels during exercise in a specific region of the brain called the ventral striatum where the reward circuits are located.
It is well established that physical exercise, practised on a regular basis, decreases the risk of developing chronic diseases, improves cognitive function, and decreases the risk of dying prematurely. To be able to take full advantage of these many benefits, it is necessary to exercise regularly and preferably over long periods of time. Yet many people have a sedentary lifestyle, and motivation to exercise is low or non-existent. Motivation to exercise is regulated in the central nervous system and requires signals initiated by dopamine, a neurotransmitter involved in a host of functions including motor control, attention, memory, cognition, sleep, pleasure and motivation. Neurons that produce dopamine are found in regions of the brain called the ventral tegmental area and the substancia nigra. Dopaminergic neurons extend into other parts of the brain to regulate cognitive, emotional, and motivational aspects related to reward-associated behaviours.
Does the motivation to exercise depend solely on our brain and our state of mind regarding this activity? It seems not, according to a recent study carried out on mice which shows that motivation is partly attributable to bacteria present in the intestine. A surprising discovery that is the result of the combined efforts of several teams of researchers.
In order to identify new regulators of exercise performance, the researchers used a cohort of 199 mice with high genetic diversity. The cohort of mice was subjected to extensive genome, metabolome, microbiome analyses, and their exercise performance was evaluated (treadmill, exercise wheel). Genomic analyses suggest that genes contribute very little to the observed differences between the exercise performance of different mice.
Since previous work (see here, here, here, and here) suggested that the microbiome would have a potential role on performance during exercise, the researchers wanted to test whether the variability in the performance of different mice could be attributed to the microbiome, by performing “loss of function” (depletion of the microbiome) and “gain of function” (transplantation of the microbiome) experiments. Complete depletion of the microbiome with broad-spectrum antibiotics caused a decrease in the mice’s exercise performance by approximately 50%. On the contrary, transplantation of the microbiome from exercise-performing mice to “germ-free” mice (raised under sterile conditions and containing no microorganisms) increased the exercise performance of the recipient mice. In addition, the exercise performance of the recipient mice correlated with that of the donor mice. When the broad-spectrum antibiotic treatments were stopped, the exercise performance of the mice returned to normal, as did that of the germ-free mice when they were no longer kept under sterile conditions. Taken together, the results of these experiments suggest that the microbiome strongly contributes to the ability to exercise in mice.
In order to identify the class of microorganisms and more precisely which bacteria contribute to the increase in exercise performance, the mice were treated with narrower-spectrum antibiotics, and the intestines of germ-free mice were colonized with a single microorganism. Among the bacteria tested, those of the genera Eubacterium and Coprococcusimproved the exercise performance of mice, to levels comparable to those observed for mice that received a whole microbiome transplant.
At the mechanistic level, the researchers first tested whether the improvement in exercise performance by the microbiome was not caused by a favourable effect on muscle function. However, the results of several tests indicate that the microbiome has no significant effect on muscle physiology. The researchers’ attention then turned to motivation, one of the important factors contributing to exercise performance, along with musculoskeletal function.
One region of the brain that is particularly involved in motivation control is the striatum. As expected, levels of the main neurotransmitter involved in motivation/reward neural signals in the striatum, dopamine, increased after the mice exercised. However, this increase was much less significant in mice whose microbiome was depleted, indicating a role of the microbiome in the release of dopamine after exercise. Levels of two other important neurotransmitters in the striatum, namely glutamate and acetylcholine, did not change following exercise or microbiome depletion.
How can bacteria that colonize the gut boost dopamine levels in the brain? There are two possible pathways: 1) through circulating factors, i.e., metabolites produced by bacteria or 2) through afferent neural circuits. Proteomic analyses of blood samples did not identify any metabolites significantly associated with exercise performance that are related to the microbiome. The researchers therefore focused on the sensory neurons that innervate the intestine.
The researchers used a line of mice (Trpv1DTA) in which a large part of the afferent vagus and spinal nerves that express the vanilloid receptor are absent. The exercise performance of Trpv1DTA mice is low, comparable to that of normal mice whose microbiome has been depleted by antibiotics. Microbiome depletion in Trpv1DTA mice did not alter exercise performance.
How can gut bacteria activate sensory nerves in the gut? The researchers showed that, in vitro, isolated spinal nerve neurons are activated by fecal extracts from normal mice, but much less by extracts from mice without microbiome. This result suggests that a metabolite from the microbiome is involved in the activation of sensory nerves. Metabolomics analyses identified candidates, several of the most potent of which were fatty acid amides (FAAs), such as N-oleoylethanolamide (OEA).
In order to prove that these compounds alone can boost exercise performance, the researchers introduced supplements of five FAAs to the diets of mice whose microbiome had been depleted by antibiotics. This supplementation restored signals generated by sensory nerves, increased levels of dopamine in the brain, and exercise performance. Then, the clever researchers transformed E. coli bacteria that normally do not produce FAA by introducing the genes responsible for the production of these metabolites. The intestines of germ-free mice were colonized with this bacterium modified to produce FAAs or with the parental line which does not produce FAAs. Exercise performance was improved by colonization with the FAA-producing bacteria, but not by colonization with the parent bacteria. Finally, the researchers showed that the effect of FAAs is mediated by cannabinoid type 1 (CB1) receptors, located in the sensory nerves in the intestine and which are connected to the brain via the spinal cord.
Studies done on mice don’t always translate to humans, but both have a similar endocannabinoid system connected to the ventral striatum. The results of this study suggest possible diet-based interventions to increase people’s motivation to exercise and optimize performance in elite athletes.
Dr Martin Juneau, M.D., FRCPCardiologue et Directeur de la prévention, Institut de Cardiologie de Montréal. Professeur titulaire de clinique, Faculté de médecine de l'Université de Montréal. / Cardiologist and Director of Prevention, Montreal Heart Institute. Clinical Professor, Faculty of Medicine, University of Montreal.14 December 2022
- Participants in a study who exercised in the late morning had a 16% lower risk of a coronary event and a 17% lower risk of a stroke compared to those who exercised at another time of day.
- These effects were particularly pronounced in women, but are non-significant when considering data for men only.
- These results illustrate the potential importance of chronoactivity in the prevention of cardiovascular disease.
Is it better to exercise in the morning or later in the day to reduce the risk of cardiovascular disease? This is a question that Dutch researchers have tried to answer in a study of 86,657 participants in the UK-Biobank cohort, aged 62 on average. Participants’ physical activity data was collected at the start of the study using a wrist-worn triaxial accelerometer over a 7-day period. Six years after the start of the study, 3,707 cardiovascular events had been reported. Participants who exercised late in the morning had a 16% lower risk of a coronary event and a 17% lower risk of a stroke, compared to those who exercised at another time of day.
These effects were particularly pronounced in women. In contrast, most of the favourable associations of morning physical activity disappeared when the researchers analyzed data from men only. This difference remains unexplained and raises the possibility that a confounding factor may be the cause. Do women who exercise in the morning have better lifestyle habits, unrelated to physical exercise, such as better diet?
Previous studies had shown a favourable association between morning physical activity and better cardiometabolic health, both for obesity (see here, here and here), type 2 diabetes, and hypertension. However, a number of studies have shown completely opposite results. For example, a recent study in Brazil indicates that for hypertensive men, evening exercise was more effective than morning exercise in restoring the heart rate and lowering blood pressure. Additionally, a Swedish study of men with type 2 diabetes indicates that high-intensity interval training (HIIT) performed in the afternoon was more effective than morning exercise in improving blood sugar levels. It should be noted that these last two intervention studies are of the “randomized and controlled” type, a study design that provides a relatively high level of scientific evidence, even if these studies were carried out with a small number of participants.
Further studies will be needed to better understand the chronoactivity phenomena, but regardless of whether it is done in the morning, afternoon or evening, it is well established that physical exercise is beneficial for cardiovascular health, mental health and overall health.
Dr Martin Juneau, M.D., FRCPCardiologue et Directeur de la prévention, Institut de Cardiologie de Montréal. Professeur titulaire de clinique, Faculté de médecine de l'Université de Montréal. / Cardiologist and Director of Prevention, Montreal Heart Institute. Clinical Professor, Faculty of Medicine, University of Montreal.17 November 2022
Only 51% of patients with type 2 diabetes succeed in properly controlling their blood sugar, i.e., reaching the therapeutic target of <7% glycated hemoglobin (HbA1c). The quantification of glycated hemoglobin is a reflection of long-term blood glucose (about 2–3 months), unlike fasting blood glucose, which is a snapshot of the glycemic state. Thus, the higher the blood sugar level over a prolonged period in an individual, the higher the proportion of glycated hemoglobin (containing a sugar) will be. The normal HbA1c value is between 3.5% and 6%.
Why do half of patients with type 2 diabetes fail to control their blood sugar, despite the wide variety of medications available to manage high blood sugar? Several factors contribute to this inadequate glycemic control, including polypharmacy (use of multiple drugs), socio-economic status, psychiatric disorders, and health disparities.
One way to improve blood sugar control by people with diabetes is through holistic activity (involving the body and the mind), such as yoga, qigong, guided imagery, mindfulness-based stress reduction (MBSR), and other forms of meditation. Researchers recently conducted a systematic review and meta-analysis of studies on the effect of holistic interventions on glycemic control in diabetics. The results of the meta-analysis, which included 28 intervention studies published between 1993 and 2022, indicate that, overall, holistic practices significantly lower the level of glycated hemoglobin or HbAc1 by 0.84%. Reductions in HbAc1 (and therefore better glycemic control) were observed for all types of intervention: MBSR: -0.48%; qigong: -0.66%; and yoga: -1.00%. The duration of yoga sessions did not have a significant effect on the HbAc1 level, but the frequency did: for each additional day with a yoga session, the HbAc1 level decreased by an average of 0.22%. Fasting blood glucose was also significantly improved following the holistic practices, with an average decrease of 22.81 mg/dL.
These reductions in glycated hemoglobin and fasting blood glucose levels are clinically significant, suggesting that mind-body practices may be effective complementary non-pharmacological interventions for people with diabetes.
Dr Martin Juneau, M.D., FRCPCardiologue et Directeur de la prévention, Institut de Cardiologie de Montréal. Professeur titulaire de clinique, Faculté de médecine de l'Université de Montréal. / Cardiologist and Director of Prevention, Montreal Heart Institute. Clinical Professor, Faculty of Medicine, University of Montreal.4 October 2022
Smoking is directly responsible for 8 million deaths worldwide each year, mainly from cancer (30% of all cancers are due to tobacco) and cardiovascular and respiratory diseases. There is therefore clearly nothing worse than cigarettes for health, and quitting smoking remains, by far, the best decision a person can make to reduce their risk of premature death.
In recent years, electronic cigarettes have emerged as a valid alternative to tobacco cigarettes to reduce the harmful effects of smoking on health. This approach is based on a relatively simple concept: while tobacco addiction is due to nicotine, it is rather the tobacco combustion products present in cigarette smoke that are responsible for smoking-related health problems. If we can satisfy smokers’ nicotine needs while eliminating exposure to cigarette smoke, we can therefore substantially reduce the damage to their health. This is exactly what e-cigarettes do, as these devices allow nicotine to be inhaled, but without the approximately 7,000 chemical compounds found in cigarette smoke, and therefore expose users to much lower amounts of toxins. This marked decrease in toxic molecules in e-cigarette aerosols has been confirmed by several independent bodies (Public Health England, National Academies of Sciences, Engineering, and Medicine and the Committee on Toxicity of Chemicals in Food, Consumer Products, and the Environment), and it is for this reason that organizations such as Public Health England and the Académie nationale de médecine in France strongly recommend that smokers make the transition to vaping.
A study recently published in Circulation, the flagship journal of the American Heart Association, is a good illustration of the positive impact of this harm reduction approach. In this longitudinal study, approximately 32,000 American adults were followed for a period of 6 years (2013–2019) to assess the risk of cardiovascular diseases (heart attack, stroke, heart failure) in smokers compared to non-smokers, exclusive e-cigarette users, and dual users (tobacco and e-cigarette).
The researchers first observed, unsurprisingly, that smokers had a much higher risk of heart disease (almost 2 times) than non-smokers (see Figure 1).
Figure 1. Increased risk of cardiovascular disease in smokers, but not in e-cigarette users (vapers). Adapted from Berlowitz et al. (2022).
However, this increase is not observed for exclusive e-cigarette users (15% increase, statistically insignificant), consistent with two recent studies (here and here). In other words, the very strong and well-documented link between smoking and cardiovascular disease is simply not observed for vaping, confirming the much lower toxicity of these devices compared to cigarette smoke. It should, however, be mentioned that dual users (who smoke and vape) have a risk of cardiovascular disease of the same order as that of smokers, which indicates that the residual exposure to tobacco toxins, even if it is slightly reduced in these people, remains harmful and sufficient to damage the heart and blood vessels.
The superiority of e-cigarette use is also highlighted when directly comparing the risk of cardiovascular events between smokers and vapers, with a reduction of about 34% in the risk observed among exclusive vapers (Figure 2). Here again, the benefits provided by e-cigarettes are completely cancelled out in dual users, and it therefore seems clear that to be truly effective in terms of harm reduction, electronic cigarettes must be a substitute for tobacco and not simply a complement, for example to obtain a dose of nicotine when it is not possible to smoke a cigarette.
Figure 2. Decreased risk of cardiovascular disease in vapers, but not in dual users. Adapted from Berlowitz et al. (2022).
These results are extremely important, because even though we already knew that e-cigarettes were safer than tobacco cigarettes, this is the first time that we have been able to quantify the reduction in risk associated with the transition from tobacco to exclusive vaping. It goes without saying that a one-third reduction in the risk of cardiovascular events has major implications in terms of public health and should prompt governments to encourage smokers to adopt vaping to reduce their risk of chronic diseases and premature mortality.